Skip to main content
SleepCited
Figure 3
Figure 3.

Scatter plots demonstrating the relationship between selected amino acids and/or ratios stratified by gender. Kyn/Trp = kynurenine to tryptophan ratio. (a) Higher neopterin values correlated with enhanced IDO-activity (as reflected by Kyn/Trp). (b) Low tryptophan values correlated significantly with low tyrosine levels. (c) Patients with low tryptophan concentrations also presented with low phenylalanine.

Description

Analysis of inflammatory or tryptophan-kynurenine pathway metabolites in post-COVID participants, indicating associations with fatigue, neurological symptoms, or insomnia.

Figure 3

Chart

Source Paper

Persistent Symptoms and IFN-γ-Mediated Pathways after COVID-19.

Journal of personalized medicine (2023)

PMID: 37511668

DOI: 10.3390/jpm13071055

Cite This Figure

![Figure 3: Analysis of inflammatory or tryptophan-kynurenine pathway metabolites in post-COVID participants, indicating associations with fatigue, neurological symptoms, or insomnia.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382041/bin/jpm-13-01055-g003.jpg)

> Source: Talia Piater et al. "Persistent Symptoms and IFN-γ-Mediated Pathways after COVID-19.." *Journal of personalized medicine*, 2023. PMID: [37511668](https://pubmed.ncbi.nlm.nih.gov/37511668/)
<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382041/bin/jpm-13-01055-g003.jpg" alt="Analysis of inflammatory or tryptophan-kynurenine pathway metabolites in post-COVID participants, indicating associations with fatigue, neurological symptoms, or insomnia." />
  <figcaption>Figure 3. Analysis of inflammatory or tryptophan-kynurenine pathway metabolites in post-COVID participants, indicating associations with fatigue, neurological symptoms, or insomnia.<br>  Source: Talia Piater et al. "Persistent Symptoms and IFN-γ-Mediated Pathways after COVID-19.." <em>Journal of personalized medicine</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37511668/">37511668</a></figcaption>
</figure>